BIO-RAD LABORATORIES, INC. Proceeds from Sale of Debt Securities, Available-for-sale
BIO-RAD LABORATORIES, INC. (BIO.B) reported Proceeds from Sale of Debt Securities, Available-for-sale of $271.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt · last filed 2026-08-04
- BIO-RAD LABORATORIES, INC. proceeds from sale of debt securities, available-for-sale for the quarter ending 2026-06-30 was $126.80M, a 53.79% decline year-over-year.
- BIO-RAD LABORATORIES, INC. proceeds from sale of debt securities, available-for-sale for the quarter ending 2026-03-31 was $145.10M, a 15.25% decline year-over-year.
- BIO-RAD LABORATORIES, INC. proceeds from sale of debt securities, available-for-sale for the quarter ending 2025-12-31 was $147.40M, a 28.27% decline year-over-year.
- BIO-RAD LABORATORIES, INC. proceeds from sale of debt securities, available-for-sale for the quarter ending 2025-09-30 was $200.60M, a 44.89% decline year-over-year.
- BIO-RAD LABORATORIES, INC. proceeds from sale of debt securities, available-for-sale for fiscal 2025 was $793.60M, a 28.25% decline from fiscal 2024.
- BIO-RAD LABORATORIES, INC. proceeds from sale of debt securities, available-for-sale for fiscal 2024 was $1.11B, a 120.36% increase from fiscal 2023.
- BIO-RAD LABORATORIES, INC. proceeds from sale of debt securities, available-for-sale for fiscal 2023 was $501.90M, a 29.13% decline from fiscal 2022.
- BIO-RAD LABORATORIES, INC. proceeds from sale of debt securities, available-for-sale for fiscal 2022 was $708.20M, a 66.43% increase from fiscal 2021.
| Period end | Proceeds from Sale of Debt Securities, Available-for-sale 3 month | Proceeds from Sale of Debt Securities, Available-for-sale 3 month as first filed | Proceeds from Sale of Debt Securities, Available-for-sale 6 month | Proceeds from Sale of Debt Securities, Available-for-sale 6 month as first filed | Proceeds from Sale of Debt Securities, Available-for-sale 9 month | Proceeds from Sale of Debt Securities, Available-for-sale 9 month as first filed | Proceeds from Sale of Debt Securities, Available-for-sale 12 month | Proceeds from Sale of Debt Securities, Available-for-sale 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $126.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $271.90M 10-Q · filed 2026-08-04 | $419.30M derived: sum of 3 quarters · filed 2026-08-04 | $619.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $145.10M 10-Q · filed 2026-04-30 | $292.50M derived: sum of 2 quarters · filed 2026-04-30 | $493.10M derived: sum of 3 quarters · filed 2026-04-30 | $767.50M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $147.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $348.00M derived: sum of 2 quarters · filed 2026-02-13 | $622.40M derived: sum of 3 quarters · filed 2026-08-04 | $793.60M 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $200.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $475.00M derived: sum of 2 quarters · filed 2026-08-04 | $646.20M 10-Q · filed 2025-10-29 | $851.70M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $274.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $445.60M 10-Q · filed 2026-08-04 | $651.10M derived: sum of 3 quarters · filed 2026-08-04 | $1.02B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $171.20M 10-Q · filed 2026-04-30 | $376.70M derived: sum of 2 quarters · filed 2026-04-30 | $740.70M derived: sum of 3 quarters · filed 2026-04-30 | $945.70M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $205.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $569.50M derived: sum of 2 quarters · filed 2026-02-13 | $774.50M derived: sum of 3 quarters · filed 2026-02-13 | $1.11B 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $364.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $569.00M derived: sum of 2 quarters · filed 2025-10-29 | $900.50M 10-Q · filed 2025-10-29 | $900.49M 10-Q · filed 2024-10-31 | $1.06B derived: sum of 4 quarters · filed 2026-02-13 | |||
| 2024-06-30 | $205.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $536.50M 10-Q · filed 2025-07-31 | $536.54M 10-Q · filed 2024-08-02 | $699.37M derived: sum of 3 quarters · filed 2026-02-13 | $842.47M derived: sum of 4 quarters · filed 2026-02-13 | |||
| 2024-03-31 | $331.50M 10-Q · filed 2025-05-01 | $331.46M 10-Q · filed 2024-05-08 | $494.37M derived: sum of 2 quarters · filed 2026-02-13 | $637.47M derived: sum of 3 quarters · filed 2026-02-13 | $740.65M derived: sum of 4 quarters · filed 2026-02-13 | |||
| 2023-12-31 | $162.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $305.97M derived: sum of 2 quarters · filed 2026-02-13 | $409.15M derived: sum of 3 quarters · filed 2026-02-13 | $501.90M 10-K · filed 2026-02-13 | $501.94M 10-K · filed 2024-02-16 | |||
| 2023-09-30 | $143.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $246.28M derived: sum of 2 quarters · filed 2024-10-31 | $339.03M 10-Q · filed 2024-10-31 | $504.59M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-06-30 | $103.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $195.93M 10-Q · filed 2024-08-02 | $361.49M derived: sum of 3 quarters · filed 2025-02-14 | $590.81M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-03-31 | $92.75M 10-Q · filed 2024-05-08 | $258.31M derived: sum of 2 quarters · filed 2025-02-14 | $487.63M derived: sum of 3 quarters · filed 2025-02-14 | $768.86M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2022-12-31 | $165.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $394.88M derived: sum of 2 quarters · filed 2025-02-14 | $676.10M derived: sum of 3 quarters · filed 2025-02-14 | $708.20M 10-K · filed 2025-02-14 | $708.21M 10-K · filed 2023-02-17 | |||
| 2022-09-30 | $229.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $510.54M derived: sum of 2 quarters · filed 2023-10-27 | $542.64M 10-Q · filed 2023-10-27 | $912.69M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-06-30 | $281.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $313.32M 10-Q · filed 2023-08-04 | $683.37M derived: sum of 3 quarters · filed 2024-02-16 | $706.06M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-03-31 | $32.10M 10-Q · filed 2023-05-05 | $402.15M derived: sum of 2 quarters · filed 2024-02-16 | $424.83M derived: sum of 3 quarters · filed 2024-02-16 | $442.01M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2021-12-31 | $370.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $392.74M derived: sum of 2 quarters · filed 2024-02-16 | $409.91M derived: sum of 3 quarters · filed 2024-02-16 | $425.54M 10-K · filed 2024-02-16 | ||||
| 2021-09-30 | $22.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $39.86M derived: sum of 2 quarters · filed 2022-10-28 | $55.49M 10-Q · filed 2022-10-28 | $69.22M derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2021-06-30 | $17.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $32.80M 10-Q · filed 2022-07-29 | $46.54M derived: sum of 3 quarters · filed 2023-02-17 | $59.64M derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2021-03-31 | $15.62M 10-Q · filed 2022-04-29 | $29.36M derived: sum of 2 quarters · filed 2023-02-17 | $42.46M derived: sum of 3 quarters · filed 2023-02-17 | $65.69M derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2020-12-31 | $13.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $26.84M derived: sum of 2 quarters · filed 2023-02-17 | $50.06M derived: sum of 3 quarters · filed 2023-02-17 | $89.73M 10-K · filed 2023-02-17 | ||||
| 2020-09-30 | $13.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $36.33M derived: sum of 2 quarters · filed 2021-10-29 | $76.00M 10-Q · filed 2021-10-29 | $97.31M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-06-30 | $23.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $62.89M 10-Q · filed 2021-07-30 | $84.21M derived: sum of 3 quarters · filed 2022-02-11 | $117.48M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-03-31 | $39.67M 10-Q · filed 2021-04-30 | $60.99M derived: sum of 2 quarters · filed 2022-02-11 | $94.26M derived: sum of 3 quarters · filed 2022-02-11 | $121.98M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2019-12-31 | $21.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $54.59M derived: sum of 2 quarters · filed 2022-02-11 | $82.31M derived: sum of 3 quarters · filed 2022-02-11 | $104.63M 10-K · filed 2022-02-11 | ||||
| 2019-09-30 | $33.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $60.99M derived: sum of 2 quarters · filed 2020-10-30 | $83.31M 10-Q · filed 2020-10-30 | |||||
| 2019-06-30 | $27.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $50.04M 10-Q · filed 2020-07-31 | ||||||
| 2019-03-31 | $22.32M 10-Q · filed 2020-05-08 | |||||||
| 2018-09-30 | $25.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $60.49M 10-Q · filed 2018-11-05 | ||||||
| 2018-06-30 | $34.55M 10-Q · filed 2018-08-09 |